Request Demo
Last update 08 May 2025
WXWH-0240
Last update 08 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism CDK2 inhibitors(Cyclin-dependent kinase 2 inhibitors), CDK4 inhibitors(Cyclin-dependent kinase 4 inhibitors), CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with WXWH-0240CTR20212695
WXWH0240片在HR+/HER2-的乳腺癌和复发/难治性卵巢癌等晚期实体瘤患者中安全性、耐受性、药代动力学特征及初步抗肿瘤活性的I期剂量递增和剂量扩展研究
[Translation] A phase I dose-escalation and dose-expansion study of the safety, tolerability, pharmacokinetic characteristics and preliminary antitumor activity of WXWH0240 tablets in patients with advanced solid tumors such as HR+/HER2- breast cancer and relapsed/refractory ovarian cancer
100 Clinical Results associated with WXWH-0240
Login to view more data
100 Translational Medicine associated with WXWH-0240
Login to view more data
100 Patents (Medical) associated with WXWH-0240
Login to view more data
100 Deals associated with WXWH-0240
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 07 Dec 2021 | |
| Hormone receptor positive HER2 negative breast cancer | Phase 1 | China | 07 Dec 2021 | |
| Ovarian Cancer | Phase 1 | China | 07 Dec 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free